Wai M. Liu

2.3k total citations
55 papers, 1.4k citations indexed

About

Wai M. Liu is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Wai M. Liu has authored 55 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 12 papers in Pharmacology and 12 papers in Oncology. Recurrent topics in Wai M. Liu's work include Cannabis and Cannabinoid Research (10 papers), Immunotherapy and Immune Responses (9 papers) and Multiple Myeloma Research and Treatments (6 papers). Wai M. Liu is often cited by papers focused on Cannabis and Cannabinoid Research (10 papers), Immunotherapy and Immune Responses (9 papers) and Multiple Myeloma Research and Treatments (6 papers). Wai M. Liu collaborates with scholars based in United Kingdom, United States and Switzerland. Wai M. Liu's co-authors include Angus Dalgleish, Katherine A. Scott, Daniel Fowler, Peter L. Smith, Thomas Powles, Jonathan Shamash, Simon Joel, David Propper, Julian Kenyon and Jayne L. Dennis and has published in prestigious journals such as Blood, Cancer Research and Oncogene.

In The Last Decade

Wai M. Liu

54 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wai M. Liu United Kingdom 20 412 377 370 305 195 55 1.4k
Mauro Piacentini Italy 9 267 0.6× 152 0.4× 913 2.5× 236 0.8× 161 0.8× 10 1.7k
Xuedong Fan United States 13 413 1.0× 317 0.8× 384 1.0× 367 1.2× 78 0.4× 19 1.3k
Hong Qi United States 17 115 0.3× 256 0.7× 567 1.5× 202 0.7× 64 0.3× 27 1.5k
Catherine Lombard Belgium 17 478 1.2× 85 0.2× 263 0.7× 197 0.6× 263 1.3× 41 1.1k
E. R. Pettipher United States 24 323 0.8× 261 0.7× 473 1.3× 519 1.7× 126 0.6× 31 1.8k
Waldemar Gonsiorek United States 19 514 1.2× 450 1.2× 552 1.5× 933 3.1× 105 0.5× 28 2.0k
Brian Gardner United States 18 712 1.7× 664 1.8× 494 1.3× 787 2.6× 130 0.7× 27 2.1k
Peer W. F. Karmaus United States 18 232 0.6× 186 0.5× 502 1.4× 760 2.5× 91 0.5× 38 1.4k
Eduardo Pérez Salazar Mexico 27 128 0.3× 364 1.0× 1.1k 2.9× 140 0.5× 128 0.7× 60 1.9k
Zia Shariat‐Madar United States 26 149 0.4× 245 0.6× 558 1.5× 297 1.0× 92 0.5× 61 1.9k

Countries citing papers authored by Wai M. Liu

Since Specialization
Citations

This map shows the geographic impact of Wai M. Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wai M. Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wai M. Liu more than expected).

Fields of papers citing papers by Wai M. Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wai M. Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wai M. Liu. The network helps show where Wai M. Liu may publish in the future.

Co-authorship network of co-authors of Wai M. Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Wai M. Liu. A scholar is included among the top collaborators of Wai M. Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wai M. Liu. Wai M. Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dalgleish, Angus & Wai M. Liu. (2022). The role of immune modulation and anti‑inflammatory agents in the management of prostate cancer: A case report of six patients. Oncology Letters. 24(2). 247–247. 4 indexed citations
2.
Adhikary, Sanjib Das, et al.. (2020). Analgesic efficacy of ketamine and magnesium after laparoscopic sleeve gastrectomy: A randomized, double-blind, placebo-controlled trial. Journal of Clinical Anesthesia. 68. 110097–110097. 6 indexed citations
3.
Kenyon, Julian, Wai M. Liu, & Angus Dalgleish. (2018). Report of Objective Clinical Responses of Cancer Patients to Pharmaceutical-grade Synthetic Cannabidiol. Anticancer Research. 38(10). 5831–5835. 55 indexed citations
4.
Williams, Ian D., Sanjeev Krishna, Ksenija Slavić, et al.. (2016). Methylene Homologues of Artemisone: An Unexpected Structure–Activity Relationship and a Possible Implication for the Design of C10‐Substituted Artemisinins. ChemMedChem. 11(13). 1469–1479. 17 indexed citations
5.
Liu, Wai M., et al.. (2016). Naltrexone at low doses upregulates a unique gene expression not seen with normal doses: Implications for its use in cancer therapy. International Journal of Oncology. 49(2). 793–802. 24 indexed citations
6.
Scott, Katherine A., Angus Dalgleish, & Wai M. Liu. (2014). The Combination of Cannabidiol and Δ9-Tetrahydrocannabinol Enhances the Anticancer Effects of Radiation in an Orthotopic Murine Glioma Model. Molecular Cancer Therapeutics. 13(12). 2955–2967. 117 indexed citations
7.
8.
Liu, Wai M., et al.. (2010). The antimalarial agent artesunate possesses anticancer properties that can be enhanced by combination strategies. International Journal of Cancer. 128(6). 1471–1480. 58 indexed citations
9.
Liu, Wai M., et al.. (2010). In vitro study of the anti-cancer effects of artemisone alone or in combination with other chemotherapeutic agents. Cancer Chemotherapy and Pharmacology. 67(3). 569–577. 45 indexed citations
10.
Liu, Wai M., et al.. (2009). Gemcitabine and lenalidomide combination in a patient with metastatic pancreatic cancer: a case study. Medical Oncology. 27(2). 430–433. 7 indexed citations
11.
Liu, Wai M., Holger Laux, Jake Y. Henry, et al.. (2009). A microarray study of altered gene expression in colorectal cancer cells after treatment with immunomodulatory drugs: differences in action in vivo and in vitro. Molecular Biology Reports. 37(4). 1801–1814. 23 indexed citations
12.
Liu, Wai M., Daniel Fowler, Peter L. Smith, & Angus Dalgleish. (2009). Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses. British Journal of Cancer. 102(1). 115–123. 286 indexed citations
13.
Liu, Wai M., Katherine A. Scott, Jonathan Shamash, Simon Joel, & Thomas Powles. (2008). Enhancing thein vitrocytotoxic activity of Δ9-tetrahydrocannabinol in leukemic cells through a combinatorial approach. Leukemia & lymphoma. 49(9). 1800–1809. 42 indexed citations
14.
Liu, Wai M.. (2008). Enhancing the Cytotoxic Activity of Novel Targeted Therapies – Is There a Role for a Combinatorial Approach?. Current Clinical Pharmacology. 3(2). 108–117. 16 indexed citations
15.
Liu, Sai & Wai M. Liu. (2007). Recent Developments in the Understanding of Nuclear Protein Import. Protein and Peptide Letters. 14(7). 723–733. 3 indexed citations
16.
Liu, Wai M., Sandra J. Strauss, Tracy Chaplin, et al.. (2004). s-Thalidomide has a greater effect on apoptosis than angiogenesis in a multiple myeloma cell line. The Hematology Journal. 5(3). 247–254. 19 indexed citations
17.
Liu, Wai M., et al.. (2004). The in vitro effects of CRE‐decoy oligonucleotides in combination with conventional chemotherapy in colorectal cancer cell lines. European Journal of Biochemistry. 271(13). 2773–2781. 7 indexed citations
18.
Liu, Wai M., Thomas Powles, Jonathan Shamash, et al.. (2003). Effect of haemopoietic growth factors on cancer cell lines and their role in chemosensitivity. Oncogene. 23(4). 981–990. 41 indexed citations
19.
Liu, Wai M. & Simon P. Joel. (2003). The schedule-dependent effects of etoposide in leukaemic cell lines: a function of concentration and duration. Cancer Chemotherapy and Pharmacology. 51(4). 291–296. 16 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mauro Piacentini Breakdown of academic impact, for papers by Xuedong Fan Breakdown of academic impact, for papers by Hong Qi Breakdown of academic impact, for papers by Catherine Lombard Breakdown of academic impact, for papers by E. R. Pettipher Breakdown of academic impact, for papers by Waldemar Gonsiorek Breakdown of academic impact, for papers by Brian Gardner Breakdown of academic impact, for papers by Peer W. F. Karmaus Breakdown of academic impact, for papers by Eduardo Pérez Salazar Breakdown of academic impact, for papers by Zia Shariat‐Madar
Rankless by CCL
2026